Resolution of inflammation in obesity-induced liver disease

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Rius, Bibiana ^a   López Vicario, Cristina ^a   González Périz, Ana ^a,b   Morán Salvador, Eva ^a   García Alonso, Verónica ^a   Clària, Joan ^a,b,c   Titos, Esther ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Eicosanoids; Kupffer cells; Obesity; Omega 3 fatty acids; Omega 6 fatty acids; Resolvins; Stromal vascular macrophages

Indexed keywords

EID: 84871653508     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00257     Document Type: Short Survey

References (49)

1. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005a). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722.
2. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Peta-sis, N. A., Blumberg, R. S., and Serhan, C. N. (2005b). Resolvin E1, an endogenous lipid mediator derived from omega-3 eicos-apentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U.S.A. 102, 7671-7676.
3. Bannenberg, G., and Serhan, C. N. (2010). Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Bio-phys. Acta 1801, 1260-1273.
4. Barton, G. M. (2008). A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 118, 413-420.
5. Lipoxin A4 attenuates adipose inflammation
6. Chakrabarti, S. K., Wen, Y., Dobrian, A. D., Cole, B. K., Ma, Q., Pei, H., Williams, M. D., Bevard, M. H., Van-denhoff, G. E., Keller, S. R., Gu, J., and Nadler, J. L. (2011). Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. Am. J. Physiol. Endocrinol. Metab. 300, E175-E187.
7. Chen, G. Y., and Nuñez, G. (2010). Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837.
8. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat
9. Clària, J., and Planagumà, A. (2005). Liver: the formation and actions of aspirin-triggered lipoxins. Pros taglandins Leukot. Essent. Fatty Acids 73, 277-282.
10. Clària, J., and Serhan, C. N. (1995). Aspirin triggers previously unrecognized bioactive eicosanoids by human endothelial cell-leukocyte interaction. Proc. Natl. Acad. Sci. U.S.A. 92, 9475-9479.
11. Decker, K. (1990). Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261.
12. Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U. H., and Serhan, C. N. (2008). Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848-855.
13. Donnelly, K. L., Smith, C. I., Schwarzen-berg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351.
14. Elks, C. M., and Francis, J. (2010). Central adiposity, systemic inflammation, and the metabolic syndrome. Curr. Hypertens. Rep. 12, 99-104.
15. Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., Schaefer, E. J., Wolff, S. M., and Dinarello, M. D. (1989).The effectof dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononu-clear cells. N. Engl. J. Med. 320, 265-271.
16. Ferrante, A. W. Jr. (2007). Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262, 408-414.
17. González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., and Clària, J. (2009). Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946-1957.
18. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R., López-Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., Rodés, J., and Clària, J. (2006). Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20, 2537-2539.
19. Gordon, S., and Taylor, P. R. (2005). Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
20. Candida albicans modulates host defense by biosynthe-sizing the pro-resolving mediator resolvin E1
21. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008). Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergicairway inflammation. Nat. Immunol. 9, 873-879.
22. Hellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., and Spite, M. (2011). Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25, 2399-2407.
23. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., and Serhan, C. N. (2003). Novel docosatrienes and 17S-resolvins generated from docosahex-aenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 14677-14687.
24. Horrillo, R., González-Périz, A., Martínez-Clemente, M., López-Parra, M., Ferré, N., Titos, E., Morán-Salvador, E., Deulofeu, R., Arroyo, V., and Clària, J. (2010). 5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J. Immunol. 184, 3978-3987.
25. Kaaman, M., Rydén, M., Axels-son, T., Nordström, E., Sicard, A., Bouloumié, A., Langin, D., Arner, P., and Dahlman, I. (2006). ALOX5AP expression, but not gene haplo-types, is associated with obesity and insulin resistance. Int. J. Obes. 30, 447-452.
26. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C. H., Yang, R., Petasis, N.A., and Serhan, C. N. (2010). Resolvin D1 binds human phagocytes with evidence for prore-solving receptors. Proc. Natl. Acad. Sci. U.S.A. 26, 1660-1665.
27. Mantovani, A., Sica, A., and Locati, M. (2007). New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37, 14-16.
28. Martínez, F. O., Helming, L., and Gordon, S. (2009). Alternative activation of macrophages: an immunologicfunctional perspective. Annu. Rev. Immunol. 27, 451-483.
29. Martínez-Clemente, M., Ferré, N., González-Périz, A., López-Parra, M., Horrillo, R., Titos, E., Morán-Salvador, E., Miquel, R., Arroyo, V., Funk, C. D., and Clària, J. (2010). 5-Lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hep-atocyte damage in hyperlipidemia-prone ApoE-null mice. Hepatology 51, 817-827.
30. Mehrabian, M., Schulthess, F. T., Nebo-hacova, M., Castellani, L. W., Zhou, Z., Hartiala, J., Oberholzer, J., Lusis, A. J., Maedler, K., and Allayee, H. (2008). Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia 51, 978-988.
31. Planagumà, A., Titos, E., López-Parra, M., Gaya, J., Pueyo, G., Arroyo, V., and Clària, J. (2002). Aspirin (ASA) regulates 5-lipoxygenase activity and per-oxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 16, 1937-1939.
32. Schif-Zuck, S., Gross, N., Assi, S., Rostoker, R., Serhan, C. N., and Ariel, A. (2011). Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41, 366-379.
33. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C.N. (2007). ResolvinE1and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874.
34. Serhan, C. N. (2002). Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 68-69, 433-455.
35. Serhan, C. N., Chiang, N., and Van Dyke, T. E. (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361.
36. Serhan, C. N., Clish, C. B., Bran-non, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal anti-inflammatory drugs and transcellu-lar processing. J. Exp. Med. 192, 1197-1204.
37. Serhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S. P., and Petasis, N. A. (2006). Anti-inflammatory actions of neuropro-tectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848-1859.
38. Serhan, C. N., Hamberg, M., and Samuelsson, B. (1984). Lipoxins: novel series of biologically active compounds formed from arachi-donic acid in human leukocytes. Proc. Natl. Acad. Sci. U.S.A. 81, 5335-5339.
39. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002). Resolvins: a family of bioac-tive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proin-flammation signals. J. Exp. Med. 196, 1025-1037.
40. Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., and Ser-han, C. N. (2009). Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291.
41. Sun, Y. P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., and Serhan, C. N. (2007). Resolvin D1 and its aspirin-triggered 17R epimer. Stereochem-ical assignments, anti-inflammatory properties, and enzymatic inactiva-tion. J. Biol. Chem. 282, 9323-9334.
42. Tilg, H. (2010). The role of cytokines in non-alcoholic fatty liver disease. Dig. Dis. 28, 179-185.
43. Titos, E., Clària, J., Bataller, R., Bosch-Marcé, M., Ginès, P., Jiménez, W., Arroyo, V., Rivera, F., and Rodés, J. (2000). Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. Gastroen-terology 119, 794-805.
44. Titos, E., Clària, J., Planagumà, A., López-Parra, M., González-Périz, A., Gaya, J., Miquel, R., Arroyo, V., and Rodés, J. (2005). Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. J. Leukoc. Biol. 78, 871-878.
45. Titos, E., Clària, J., Planagumà, A., López-Parra, M., Villamor, N., Par-rizas, M., Carrió, A., Miquel, R., Jiménez, W., Arroyo, V., Rivera, F., and Rodés, J. (2003). Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis. FASEB J. 17, 1745-1747.
46. Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., and Clària, J. (2011). Resolvin D1 and its precursor docosahex-aenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 15, 5408-5418.
47. Wallace, J. L., and Vong, L. (2008). NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr. Opin. Investig. Drugs 9, 1151-1156.
48. Wanninger, J., Bauer, S., Eisinger, K., Weiss, T. S., Walter, R., Heller-brand, C., Schäffler, A., Higuchi, A., Walsh, K., and Buechler, C. (2012). Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver. Mol. Cell. Endocrinol. 349, 248-254.
49. Wisse, E., Braet, F., Luo, D., De Zanger, R., Jans, D., Crabbé, E., and Vermoesen, A. (1996). Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 24, 100-111.